News

Redeye interview with Michael Brobjer

Aug 21, 2020

A new Redeye interview with Michael Brobjer, AroCell CEO, commenting interim report for the second quarter of 2020.

See the interview on Redeye’s website.

Presentation at LabRoots 2024

Martin Shaw, Business Development at AroCell, held a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can see the presentation below....

read more